wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47917650-596775E1-4A40-4ACF-B69F-B8167D61BCB3
Q47917650-596775E1-4A40-4ACF-B69F-B8167D61BCB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47917650-596775E1-4A40-4ACF-B69F-B8167D61BCB3
First-line therapy for chronic phase CML: selecting the optimal BCR-ABL1-targeted TKI.
P2860
Q47917650-596775E1-4A40-4ACF-B69F-B8167D61BCB3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47917650-596775E1-4A40-4ACF-B69F-B8167D61BCB3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d7c194bf9138a5999c348f220fc3e4e72f1936e
P2860
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.